Skip to content

Price / book at other companies

Schrodinger logo
SchrodingerSDGR
2.7×-1.2×
Certara, Inc. logo
Certara, Inc.CERT
0.9×-0.6×
Charles River Laboratories logo
Charles River LaboratoriesCRL
2.9×+0.5×
Personalis, Inc. logo
Personalis, Inc.PSNL
2.6×+1.1×
NeoGenomics logo
NeoGenomicsNEO
1.2×-0.2×
Opko Health logo
Opko HealthOPK
0.7×-0.1×

Other financials

Income statement

See full
Revenue$24.3M+8.3%
Gross profit$16.1M+23.0%
Operating income$5.6M+108%
Net income$4.5M+47.5%
EPS (diluted)$0.22+46.7%

Balance sheet

See full
Cash & equivalents$25.7M+134%
Total debt$508.0K-36.2%
Total equity$133.8M-29.4%
Total assets$146.5M-27.3%

Cash flow

See full
Operating cash flow$6.4M+13.1%
CapEx$46.0K-30.3%
Free cash flow$6.4M+13.6%

Valuation

See full
Market cap$366.73M+5.2%
Enterprise value$341.51M+6.0%
P/S4.6×+0.2×

Profitability

See full
Gross margin62%+6.7pp
Operating margin-84.3%
Net margin-78%-87.2pp
FCF margin29.5%+14.9pp

Returns & leverage

See full
Return on equity-38.8%-42.8pp
Debt / equity0.0×
Current ratio5.5×+1.1×

Where this comes from

Calculated from Simulations Plus’s reported figures.

Based on the most recent quarter.

The official record: Simulations Plus’s 10-Q, filed April 10, 2026, on SEC EDGAR. View the filing →

Ask your AI about Simulations Plus's price / book.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Simulations Plus's price / book?
Simulations Plus (SLP) reported price / book of 1.8× in Q4 2025.
How has Simulations Plus's price / book changed year-over-year?
Simulations Plus's price / book decreased by 40.0% year-over-year, from 3.1× to 1.8×.
What is the long-term trend for Simulations Plus's price / book?
Over 5 years (2020 to 2025), Simulations Plus's price / book has grown at a -21.4% compound annual growth rate (CAGR), from 7.6× to 2.3×.
What does price / book mean?
Market capitalization at the quarter end divided by shareholders' equity. The premium (or discount) the market assigns to the company's book equity.